Register now for a personalized educational experience.
Already a member? Log In
By linking my Doximity account with UPMC Physician Resources, I acknowledge that:
Forgot your password? Enter the email address you used to create your account to initiate a password reset.
Dr. Adriana Zeevi discusses how you define and approach a sensitized patient.
Upon completion of this activity, participants should be able to:
Dr. Zeevi has reported no relevant relationships with entities producing health care goods or services
All presenters disclosure of relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients is listed above. No other planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.
The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Pittsburgh School of Medicine designates this enduring material for a maximum of .75 AMA PRA Category 1 Credits. Each physician should only claim credit commensurate with the extent of their participation in the activity. Other health care professionals are awarded (0.075) continuing education units (CEU) which are equivalent to .75 contact hour.
For your credit transcript, please access our website 4 weeks post-completion at http://ccehs.upmc.com and follow the link to the Credit Transcript page. If you do not provide the last 5 digits of your SSN on the next page you will not be able to access a CME credit transcript. Providing your SSN is voluntary.
Release Date: 1/17/2019 | Last Modified On: 1/17/2019 | Expires: 1/17/2020
1. Ensor CR, Yousem SA, Marrari M, Morrell MR, Mangiola M, Pilewski JM, D’Cunha J, Wisniewski SR, Venkataramanan R, Zeevi Adriana, McDyer JF. Proteasome inhibitor carfilzomib-based therapy for antibody –mediated rejection of the pulmonary allograft: Use and short-term findings. American Journal of Transplantation 2017 17:1380-1388
2. Levine DJ, Glanville AR, Aboyoun C, Belperio J, Benden C, Berry GJ, Hachem R, Hayes D Jr, Neil
D, Reinsmoen NL, Snyder, LD Sweet S, Tyan D, Verleden G, Westall G, Yusen RD, Zamora M, Zeevi Adriana. Antibody-Mediated rejection of the lung: A Consensus report of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant, 2016 35: 397-406
3. Matthew R. Morrell, Joseph M Pilewski, Cynthia J Gries, Matthew R. Pipeling, Maria M. Crespo, Christopher R, Ensor, Pharm D, Samuel A. Yousem, Jonathan D’Cunha, Norihisa Shigemura, Christian A Bermudez, John F. McDyer, and Zeevi Adriana. De novo donor-specific HLA antibodies are associated with early and high-grade bronchiolitis obliterans syndrome and death after lung transplantation. J Heart Lung Transplant 2014 33: 1288-1294
4. Tait BD, Süsal C, Gebel HM, Nickerson PW, Zachary AA, Class FH, Reed EF, Bray RA, Campbell P, C JR, Coates PT, Colvin RB, Cozzi E, Doxiadis II, Fuggle SV, Gill J, Glotz D, Lachmann N, Mohanakumar T, Suciu-Foca N, Sumitran-Holgersson S, Tanabe K, Taylor CJ,Tyan DB, Webster A, Zeevi Adriana Opelz G. Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation. Transplantation 2013 95: 19-47